Search research articles
Contact Us
Filters
Showing results (21-30 of 113) with videos related to
Page
of 12
Sort By:
Trends in Pharmacological Sciences
|
May 18, 2024
Emerging targets in lipid metabolism for cancer therapy
Alexander R Terry, Nissim Hay
Cell Cycle (Georgetown, Tex.)
|
April 23, 2005
Mitochondrial hexokinases: guardians of the mitochondria
R Brooks Robey, Nissim Hay
Trends in Biochemical Sciences
|
July 20, 2014
The pentose phosphate pathway and cancer
Krushna C Patra, Nissim Hay
British Journal of Cancer
|
May 31, 2017
Akt as a target for cancer therapy: more is not always better (lessons from studies in mice)
Qi Wang, Xinyu Chen, Nissim Hay
Nature Communications
|
August 8, 2024
Metabolic and transcriptomic reprogramming during contact inhibition-induced quiescence is mediated by YAP-dependent and YAP-independent mechanisms
Soeun Kang, Maciek R Antoniewicz, Nissim Hay
Elife
|
April 25, 2018
Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation
Veronique Nogueira, Krushna C Patra, Nissim Hay
The Journal of Biological Chemistry
|
January 29, 2025
A novel FOXM1-BCL2A1 axis determines unfavorable response to venetoclax in AML
Sanjeev Raghuwanshi, Ahmed Magdy, Nissim Hay, et al.
Blood
|
October 5, 2007
The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation
Hong Yin, Aleksandra Stojanovic, Nissim Hay, et al.
Nature
|
June 5, 2012
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Sang-Min Jeon, Navdeep S Chandel, Nissim Hay
Molecular and Cellular Biology
|
January 1, 2004
Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases
Nathan Majewski, Veronique Nogueira, R Brooks Robey, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 113) with videos related to
Sort By:
Page
of 12
Trends in Pharmacological Sciences
|
May 18, 2024
Emerging targets in lipid metabolism for cancer therapy
Alexander R Terry, Nissim Hay
Cell Cycle (Georgetown, Tex.)
|
April 23, 2005
Mitochondrial hexokinases: guardians of the mitochondria
R Brooks Robey, Nissim Hay
Trends in Biochemical Sciences
|
July 20, 2014
The pentose phosphate pathway and cancer
Krushna C Patra, Nissim Hay
British Journal of Cancer
|
May 31, 2017
Akt as a target for cancer therapy: more is not always better (lessons from studies in mice)
Qi Wang, Xinyu Chen, Nissim Hay
Nature Communications
|
August 8, 2024
Metabolic and transcriptomic reprogramming during contact inhibition-induced quiescence is mediated by YAP-dependent and YAP-independent mechanisms
Soeun Kang, Maciek R Antoniewicz, Nissim Hay
Elife
|
April 25, 2018
Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation
Veronique Nogueira, Krushna C Patra, Nissim Hay
The Journal of Biological Chemistry
|
January 29, 2025
A novel FOXM1-BCL2A1 axis determines unfavorable response to venetoclax in AML
Sanjeev Raghuwanshi, Ahmed Magdy, Nissim Hay, et al.
Blood
|
October 5, 2007
The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation
Hong Yin, Aleksandra Stojanovic, Nissim Hay, et al.
Nature
|
June 5, 2012
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Sang-Min Jeon, Navdeep S Chandel, Nissim Hay
Molecular and Cellular Biology
|
January 1, 2004
Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases
Nathan Majewski, Veronique Nogueira, R Brooks Robey, et al.
Page
of 12